Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from MarketBeat

Doximity (NYSE:DOCS) reported fiscal fourth-quarter revenue above the high end of its guidance and said it is entering what management called an “AI investment year,” with higher spending planned for artificial intelligence products even as near-term growth in the digital pharma advertising market r

MarketBeat

Wrap Technologies Q1 Earnings Call Highlights

Wrap Technologies (NASDAQ:WRAP) said first-quarter revenue rose 45% year-over-year as product sales for its BolaWrap 150 line accelerated, while management reiterated its goal of doubling revenue in 2026. On the company’s first-quarter 2026 earnings call, Chief Executive Officer Scot Cohen said man

MarketBeat

Energous Q1 Earnings Call Highlights

Energous (NASDAQ:WATT) reported sharply higher first-quarter revenue and a narrower loss as management said the wireless power company is moving from technology validation into commercial deployment across enterprise Internet of Things markets. On the company’s first earnings call since 2024, Chief

MarketBeat

From analysis to the latest developments in health,
read the most diverse news in one place.

USA Rare Earth Q1 Earnings Call Highlights

USA Rare Earth (NASDAQ:USAR) said its first quarter was marked by a series of strategic transactions intended to turn the company into a fully integrated rare earths platform spanning mining, processing, metals and magnet production. On the company’s first-quarter 2026 earnings call, Chief Executiv

MarketBeat

STAAR Surgical Q1 Earnings Call Highlights

STAAR Surgical (NASDAQ:STAA) said its first quarter of 2026 marked a sharp rebound in sales and profitability, driven by strong demand in China, continued growth in the U.S. and tighter cost controls following a difficult 2025. On the company’s earnings call, Interim Co-CEO, President and Chief Ope

MarketBeat

Rapid Micro Biosystems Q1 Earnings Call Highlights

Rapid Micro Biosystems (NASDAQ:RPID) reported first-quarter 2026 revenue growth and reaffirmed its full-year outlook, citing momentum in system placements, consumables and recurring revenue, while management said gross margin improvement remains a central priority for the year. President and Chief

MarketBeat

QT Imaging Q1 Earnings Call Highlights

QT Imaging (NASDAQ:QTI) reported sharply higher first-quarter 2026 revenue as scanner shipments more than doubled from the prior-year period, while management highlighted progress on reimbursement, regulatory approvals, software upgrades and international expansion during the company’s earnings call

MarketBeat

Read news from The Economist, FT, and more,
with one subscription

Sangoma Technologies Q3 Earnings Call Highlights

Sangoma Technologies (NASDAQ:SANG) lowered its full-year fiscal 2026 revenue outlook and said its board has launched a structured strategic review, as management described a business increasingly split between growing communications infrastructure assets and more pressured software and UCaaS offerin

MarketBeat

Seer Q1 Earnings Call Highlights

Seer (NASDAQ:SEER) reported lower first-quarter revenue but reaffirmed its full-year 2026 outlook, with management pointing to population-scale proteomics studies, an expanding publication base and expected second-half consumables demand as supports for the year. Total revenue for the quarter ended

MarketBeat

Precigen Q1 Earnings Call Highlights

Precigen (NASDAQ:PGEN) reported a sharp increase in first-quarter 2026 revenue as the company’s first commercial product, PAPZIMEOS, continued its U.S. launch following FDA approval in August 2025. On the company’s earnings call, President and CEO Dr. Helen Sabzevari said PAPZIMEOS generated net pr

MarketBeat

Omeros Q1 Earnings Call Highlights

Omeros (NASDAQ:OMER) reported first-quarter 2026 net income of $56.1 million, or $0.78 per share, as the company began commercial sales of YARTEMLEA, its recently approved treatment for hematopoietic stem cell transplant-associated thrombotic microangiopathy, or TA-TMA. Chairman and Chief Executive

MarketBeat

MDxHealth Q1 Earnings Call Highlights

MDxHealth (NASDAQ:MDXH) reported first-quarter 2026 revenue of $27.4 million while announcing a strategic exit from its Resolve UTI testing business and the planned closure of its Plano, Texas, laboratory facility, a move executives said will sharpen the company’s focus on prostate cancer diagnostic

MarketBeat

AEye Q1 Earnings Call Highlights

AEye (NASDAQ:LIDR) reported higher first-quarter revenue and emphasized expanding commercial engagement across defense, transportation, automotive and infrastructure markets, while management said the lidar company remains focused on converting evaluations and proofs of concept into deployments. On

MarketBeat

Lightwave Logic Q1 Earnings Call Highlights

Lightwave Logic (NASDAQ:LWLG) reported a wider first-quarter loss while outlining progress on customer engagement, foundry integration and commercialization efforts for its electro-optic polymer technology, which management said is increasingly aligned with demand from artificial intelligence networ

MarketBeat

Get all your
news in one place.

100's of premium titles.
One news app.

MarketBeat

Marchex Q1 Earnings Call Highlights

Marchex (NASDAQ:MCHX) said it is seeing improving momentum from new artificial intelligence-driven products and operating efficiencies as management outlined first-quarter 2026 results, updated adjusted EBITDA guidance and details on its proposed acquisition of Archenia, Inc. On the company’s earni

MarketBeat

Identiv Q1 Earnings Call Highlights

Identiv (NASDAQ:INVE) reported first-quarter 2026 revenue ahead of its prior guidance and outlined progress on its manufacturing transition, Bluetooth Low Energy smart-label initiatives and strategic review, while also noting emerging pressure from softer demand among some consumer-facing customers.

MarketBeat

Jack In The Box Q2 Earnings Call Highlights

Jack In The Box (NASDAQ:JACK) reported lower fiscal second-quarter earnings and same-store sales, while management said trends improved through the quarter and into the current period as the burger chain leans on value offers, premium menu innovation and operational changes. The company’s fiscal Q2

MarketBeat

Alvotech Plans June FDA Resubmissions, Sees Biosimilar Approvals by Year-End

Alvotech (NASDAQ:ALVO) Chief Strategy Officer Balaji Prasad said the biosimilar developer is preparing to resubmit three biologics license applications to the U.S. Food and Drug Administration in June after addressing manufacturing observations that led to complete response letters for pipeline prod

Get all your
news in one place.

100's of premium titles.
One news app.

MarketBeat

Health In Tech Q1 Earnings Call Highlights

Health In Tech (NASDAQ:HIT) reported first-quarter 2026 revenue growth and a wider loss as management said the company is intentionally increasing investment in sales distribution, carrier relationships and technology development to pursue a larger share of the self-funded health insurance market.

MarketBeat

Fluent Q1 Earnings Call Highlights

Fluent (NASDAQ:FLNT) reported a sharp shift in its business mix in the first quarter of 2026, with management pointing to continued rapid growth in Commerce Media Solutions as the company’s central growth driver, even as total revenue declined following the divestiture of its Call Solutions business

MarketBeat

Fossil Group Q1 Earnings Call Highlights

Fossil Group (NASDAQ:FOSL) executives said the company’s turnaround efforts continued to gain traction in the first quarter of fiscal 2026, supported by wholesale strength, improving traditional watch demand and continued expense discipline. Chief Executive Officer Franco Fogliato said Fossil began

MarketBeat

Grocery Outlet Q1 Earnings Call Highlights

Grocery Outlet (NASDAQ:GO) reported first-quarter fiscal 2026 results that management said were in line with its guidance, as the discount grocer works to restore comparable sales growth through a stronger mix of opportunistic merchandise, targeted promotions and operational changes. President and

MarketBeat

Enovix Q1 Earnings Call Highlights

Enovix (NASDAQ:ENVX) reported first-quarter 2026 revenue above its guidance range as the battery developer said it is advancing commercial production for smart eyewear, refining smartphone qualification standards with customers and building a larger pipeline in drone, defense and industrial markets.

MarketBeat

Allogene Therapeutics Q1 Earnings Call Highlights

Allogene Therapeutics (NASDAQ:ALLO) said its first quarter of 2026 was marked by early clinical progress for its lead allogeneic CAR-T programs and a strengthened cash position following an April financing. On the company’s quarterly conference call, President and Chief Executive Officer Dr. David

MarketBeat

AmpliTech Group Q1 Earnings Call Highlights

AmpliTech Group (NASDAQ:AMPG) reported sharply higher first-quarter 2026 revenue and wider gross margins, while management said it remains confident in the company’s full-year revenue outlook despite potential timing risks tied to supply chains, customer deployments and geopolitical factors. On the

1 … 27 28 29 30

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Artificial Intelligence

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.